Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Search
IASLC.org
IASLC Lung Cancer News
Home
Science & Medicine
Diagnostic Oncology
Evolving Standards of Care
FDA Corner
Global Initiatives
Immunotherapy
Lung Cancer Screening
NCI Corner
Pathology
Prevention and Tobacco Control
Radiation Oncology
Supportive Care
Targeted Therapy
Advocacy & Survivorship
Thought-Leader Perspective
Allied Health
Meetings
Highlights
Preview
News
Breaking News Briefs
In Memoriam
People
Home
News
News
Most popular
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Suresh Senan, MRCP, FRCR, PhD
lungcanc
Steven M. Keller, MD
Paolo Paoletti, MD
FDA’s New Acting Commissioner
Laurie Fenton Ambrose
Alex A. Adjei, MD, PhD, FACP
lungcanc
Primo N. Lara, Jr., MD
lungcanc
Fred Hutchinson’s New President, Director
lungcanc
Charles Swanton, MD, PhD
lungcanc
Keith Kerr, BSc, MB ChB, FRCPath, FRCPE
lungcanc
Tony Mok, BMSc, MD, FRCP(C), FRCP (Glasgow), FASCO
lungcanc
Jessica S. Donington, MD, MSCR
lungcanc
Suresh S. Ramalingam, MD
lungcanc
Breaking News Briefs
lungcanc
Howard A. “Skip” Burris III, MD
lungcanc
1
2
3
...
13
Page 1 of 13
Meeting News
Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation
Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation
TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse
cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib
Load more
Edit with Live CSS
